RT Journal Article
SR Electronic
T1 Validation of the LENT score in Japanese sample: The impact of EGFR-TKI
JF European Respiratory Journal
JO Eur Respir J
FD European Respiratory Society
SP PA4328
DO 10.1183/13993003.congress-2015.PA4328
VO 46
IS suppl 59
A1 Tamaki Takahashi
A1 Daisuke Naito
A1 Yusuke Wakatsuki
A1 Yuko Yamamoto
A1 Yoko Hamakawa
A1 Kazuki Shima
A1 Yuichi Chihara
A1 Kenichi Takahashi
A1 Hiromichi Katakura
A1 Naoki Sakai
YR 2015
UL http://erj.ersjournals.com/content/46/suppl_59/PA4328.abstract
AB Background: The LENT scoring system is a new prognostic score in malignant pleural effusion. We try to validate the scoring system in our hospital.Methods: Medical records were surveyed from January, 2012 to December. Thirty-three patients were examined pleural effusion and proven malignant. Twenty-seven of them were completely checked the LENT score and their surviving days, and they were divided into median risk group and high risk group.Results: Median risk group gave median (IQR) survivals of 55days (36-73, n=11) and high risk group gave 299 (163-651, n=16) days, respectively. In our study, 14 (87.5%) cases in high risk group were lung adenocarcinoma, and they could use EGFR-TKI and survive more than 6 months.Conclusion: LENT score might be a very good prognostic score, but it should be more concerned about the tumor type, especially in lung cancer.